Medicines for Malaria Venture donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country Switzerland
Facebook page medicinesformalaria
Websitehttps://www.mmv.org/
Donate pagehttps://www.mmv.org/partnering/our-donors/donate-mmv
Donors list pagehttps://www.mmv.org/partnering/our-donors
Twitter usernameMedsforMalaria
Wikipedia pagehttps://en.wikipedia.org/wiki/Medicines_for_Malaria_Venture

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 16 4,616,720 22,140,316 10,000 40,000 1,000,500 1,620,000 2,506,839 4,616,720 9,000,000 10,000,000 10,000,000 115,000,000 160,000,000
Global health 14 2,506,839 24,231,790 10,000 40,000 372,520 1,620,000 1,620,000 2,506,839 9,000,000 9,175,319 24,283,164 115,000,000 160,000,000
FIXME 2 5,000,000 7,500,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000

Donation amounts by donor and year for donee Medicines for Malaria Venture

Donor Total 2017 2016 2014 2013 2011 2010 2009 2007 2005
Bill and Melinda Gates Foundation (filter this donee) 339,245,062.00 1,000,500.00 4,126,839.00 35,078,483.00 164,989,240.00 9,010,000.00 10,000,000.00 115,000,000.00 40,000.00 0.00
Wellcome Trust (filter this donee) 15,000,000.00 0.00 0.00 0.00 0.00 5,000,000.00 0.00 0.00 0.00 10,000,000.00
Total 354,245,062.00 1,000,500.00 4,126,839.00 35,078,483.00 164,989,240.00 14,010,000.00 10,000,000.00 115,000,000.00 40,000.00 10,000,000.00

Full list of donations in reverse chronological order (16 donations)

DonorAmount (current USD)Amount rank (out of 16)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation1,000,500.00132017-10-24Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to increase post-approval knowledge about the safety and appropriate use of pyronaridine-artesunate in broader patient populations beyond those evaluated in the drug’s clinical development program; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation1,620,000.00112016-11-30Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,506,839.00102016-10-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to increase post-approval knowledge about the safety and appropriate use of pyronaridine-artesunate in broader patient populations beyond those evaluated in the drug’s clinical development program; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation24,283,164.0032014-10-31Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia.
Bill and Melinda Gates Foundation9,175,319.0062014-10-26Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to enable the evaluation of new antimalarial medicines with a focus on novel and easy-to-administer combination treatments that will support the elimination and eventual eradication of malaria..; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,620,000.00112014-05-08Global health/malariahttps://iatiregistry.org/publisher/bmgf-- To foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation372,520.00142013-10-22Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia.
Bill and Melinda Gates Foundation160,000,000.0012013-07-04Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to discover, develop, and facilitate access to new antimalarial medicines... Drug development to support malaria eradication [PDW]. Investment start date: 7/4/2013 to end date: 12/31/2019. Grantee name: Medicines for Malaria Venture; Aid type: Project-type interventions. Affected regions: South of Sahara|South America|Far East Asia.
Bill and Melinda Gates Foundation4,616,720.0092013-06-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to create an open-source compound collection of 400 molecules as a resource to jump-start drug discovery efforts across a wide range of pathogens; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation9,000,000.0072011-10-28Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation10,000.00162011-08-15Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for general operating support. Ian Bathurst Sponsorship Programme at MMV. Investment start date: 8/15/2011 to end date: 12/30/2011. Grantee name: Medicines for Malaria Venture; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: South of Sahara.
Wellcome Trust5,000,000.0082011-04-12FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- New medicines against malaria: demonstrating activity in man. Affected regions: International; affected countries: Switzerland.
Bill and Melinda Gates Foundation10,000,000.0042010-10-23Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation115,000,000.0022009-10-01Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to further develop and accelerate antimalarial discovery and development projects; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation40,000.00152007-08-17Global health/malariahttps://iatiregistry.org/publisher/bmgf-- for general operating support. for general operating support. Investment start date: 8/17/2007 to end date: 9/17/2007. Grantee name: Medicines for Malaria Venture; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Wellcome Trust10,000,000.0042005-09-21FIXMEhttps://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx-- Medicines for Malaria Venture. Affected regions: International; affected countries: Switzerland.